Does cesarean section pose a risk of respiratory syncytial virus bronchiolitis in infants and children?
Related Experiment Video
Updated: Apr 22, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Mohamed A Hendaus1, Ahmed H Alhammadi2, Mohamed S Khalifa1
1Department of Pediatrics, General Pediatrics Section, Hamad Medical Corporation, Doha, Qatar.
Insights
Cesarean section delivery does not increase the risk of respiratory syncytial virus (RSV) bronchiolitis in infants. Premature birth, however, significantly elevates the risk of RSV bronchiolitis in children.
Area of Science:
- Pediatrics
- Infectious Diseases
- Epidemiology
Background:
- Acute bronchiolitis is a common respiratory infection in infants and young children.
- Respiratory syncytial virus (RSV) is a primary cause of acute bronchiolitis.
- Mode of delivery has been investigated as a potential factor influencing infant health outcomes.
Purpose of the Study:
- To investigate the association between cesarean section (C-section) delivery and the risk of developing acute respiratory syncytial virus (RSV) bronchiolitis in infants and children.
- To compare the incidence of RSV bronchiolitis in infants born via C-section versus those born via normal spontaneous vaginal delivery.
Main Methods:
- A retrospective and descriptive study design was employed.
- Data were collected from patients aged 0 to 36 months hospitalized with acute bronchiolitis at Hamad Medical Corporation.
- Statistical analysis included calculation of odds ratios and confidence intervals to assess risk.
Main Results:
- The study found no statistically significant increase in the risk of RSV bronchiolitis among infants delivered by C-section compared to those born via normal spontaneous vaginal delivery (odds ratio=1.10; 95% CI [0.57, 1.80]; P=0.965).
- Infants born with a gestational age of ≤35 weeks showed a significantly higher risk of RSV bronchiolitis compared to those with a gestational age >35 weeks (odds ratio=3.12; 95% CI [1.53, 6.38]; P=0.002).
Conclusions:
- Delivery via C-section does not appear to be a significant risk factor for developing RSV bronchiolitis in infants.
- Preterm birth (gestational age ≤35 weeks) is a significant risk factor associated with an increased risk of RSV bronchiolitis.
Objective:
To determine the risk of acquiring acute respiratory syncytial virus (RSV) bronchiolitis in infants and children delivered by the mode of cesarean section (C-section).
Methods:
A retrospective and descriptive study was conducted at Hamad Medical Corporation. Patients with ages 0 to 36 months hospitalized with acute bronchiolitis were included in the study.
Results:
The risk of RSV bronchiolitis was observed to be higher among C-section delivery compared to normal spontaneous vaginal delivery [odds ratio=1.10; 95% confidence interval (0.57, 1.80); P=0.965]; however, it was not statistically significant. Gestational age ≤35 weeks was significantly associated with increased risk of RSV bronchiolitis compared to gestational age >35 weeks [odds ratio=3.12; 95% confidence interval (1.53, 6.38); P=0.002].
Conclusions:
Delivery by C-section does not appear to increase the risk of RSV bronchiolitis in infants compared with normal spontaneous vaginal delivery.
Related Concept Videos
Pulmonary Cycle: Exhalation
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Development of the Oral Microbiota
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Breathing
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

